Crystal T Clark1, Dorothy K Y Sit2, Kara Driscoll1, Heather F Eng3, Andrea L Confer4, James F Luther3, Stephen R Wisniewski3, Katherine L Wisner1. 1. Asher Center for the Study and Treatment of Depressive Disorders, Department of Psychiatry, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 2. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 3. Department of Epidemiology, Graduate School of Public Health, Epidemiology Data Center, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: Women with bipolar disorder (BD) are at high risk for postpartum affective episodes and psychosis. Although validated screening tools are available for postpartum unipolar depression, few screening tools for hypomania/mania exist. Screening tools for BD in the postpartum period are essential for improving detection and planning appropriate treatment. We evaluated whether adding the Mood Disorders Questionnaire (MDQ) to the Edinburgh Postnatal Depression Scale (EPDS) increased the identification of BD in the early postpartum period. METHODS: Women (N = 1,279) who delivered a live infant and screened positive on the EPDS and/or MDQ at 4-6 weeks postbirth were invited to undergo an in-home Structured Clinical Interview for DSM-IV (SCID). RESULTS: Positive EPDS and/or MDQ screens occurred in 12% of the sample (n = 155). In home SCID diagnostic interviews were completed in 93 (60%) of the mothers with positive screens. BD was the primary diagnosis in 37% (n = 34). Women with BD screened positive on the EPDS and/or MDQ as follows: EPDS+/MDQ+ (n = 14), EPDS+/MDQ- (n = 17), and EPDS-/MDQ+ (n = 3). The MDQ identified 50% (17/34) of the women with BD and 6 additional cases of BD when the MDQ question regarding how impaired the mother perceived herself was excluded from the screen criterion. CONCLUSION: Addition of the MDQ to the EPDS improved the distinction of unipolar depression from bipolar depression at the level of screening in 50% of women with traditional MDQ scoring and by nearly 70% when the MDQ was scored without the impairment criterion.
BACKGROUND:Women with bipolar disorder (BD) are at high risk for postpartum affective episodes and psychosis. Although validated screening tools are available for postpartum unipolar depression, few screening tools for hypomania/mania exist. Screening tools for BD in the postpartum period are essential for improving detection and planning appropriate treatment. We evaluated whether adding the Mood Disorders Questionnaire (MDQ) to the Edinburgh Postnatal Depression Scale (EPDS) increased the identification of BD in the early postpartum period. METHODS:Women (N = 1,279) who delivered a live infant and screened positive on the EPDS and/or MDQ at 4-6 weeks postbirth were invited to undergo an in-home Structured Clinical Interview for DSM-IV (SCID). RESULTS: Positive EPDS and/or MDQ screens occurred in 12% of the sample (n = 155). In home SCID diagnostic interviews were completed in 93 (60%) of the mothers with positive screens. BD was the primary diagnosis in 37% (n = 34). Women with BD screened positive on the EPDS and/or MDQ as follows: EPDS+/MDQ+ (n = 14), EPDS+/MDQ- (n = 17), and EPDS-/MDQ+ (n = 3). The MDQ identified 50% (17/34) of the women with BD and 6 additional cases of BD when the MDQ question regarding how impaired the mother perceived herself was excluded from the screen criterion. CONCLUSION: Addition of the MDQ to the EPDS improved the distinction of unipolar depression from bipolar depression at the level of screening in 50% of women with traditional MDQ scoring and by nearly 70% when the MDQ was scored without the impairment criterion.
Authors: S Nassir Ghaemi; Christopher J Miller; Douglas A Berv; Jeffry Klugman; Klara J Rosenquist; Ronald W Pies Journal: J Affect Disord Date: 2005-02 Impact factor: 4.839
Authors: J Sanjuan; R Martin-Santos; L Garcia-Esteve; J M Carot; R Guillamat; A Gutierrez-Zotes; I Gornemann; F Canellas; E Baca-Garcia; M Jover; R Navines; V Valles; E Vilella; Y de Diego; J A Castro; J L Ivorra; E Gelabert; M Guitart; A Labad; F Mayoral; M Roca; M Gratacos; J Costas; J van Os; R de Frutos Journal: Br J Psychiatry Date: 2008-11 Impact factor: 9.319
Authors: Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk Journal: Bipolar Disord Date: 2018-03-14 Impact factor: 6.744
Authors: Susan Kendig; John P Keats; M Camille Hoffman; Lisa B Kay; Emily S Miller; Tiffany A Moore Simas; Ariela Frieder; Barbara Hackley; Pec Indman; Christena Raines; Kisha Semenuk; Katherine L Wisner; Lauren A Lemieux Journal: Obstet Gynecol Date: 2017-03 Impact factor: 7.661
Authors: Melissa M Batt; Aviva K Olsavsky; Shaleah Dardar; Celeste St John-Larkin; Rachel L Johnson; Mary D Sammel Journal: Curr Psychiatry Rep Date: 2022-02-15 Impact factor: 8.081
Authors: Grace A Masters; Linda Brenckle; Padma Sankaran; Sharina D Person; Jeroan Allison; Tiffany A Moore Simas; Jean Y Ko; Cheryl L Robbins; Wendy Marsh; Nancy Byatt Journal: Gen Hosp Psychiatry Date: 2019-10-22 Impact factor: 3.238
Authors: Rafał R Jaeschke; Dominika Dudek; Roman Topór-Mądry; Katarzyna Drozdowicz; Wojciech Datka; Marcin Siwek; Janusz Rybakowski Journal: Braz J Psychiatry Date: 2016-12-08 Impact factor: 2.697